|
Opportunistic Screening’s AI Milestone | FDA Frenzy
January 13, 2025
|
|
|
|
|
Together with
|
|
|
|
“Radiologists spend most of their time reviewing normals, reporting the insignificant, and repeating the same phrases. And we wonder why we are at risk of being replaced by AI.”
|
|
Amine Korchi, MD.
|
|
|
|
A new study lays the groundwork for AI-based opportunistic screening – the detection of disease using medical images acquired for other indications. In a paper in AJR, researchers show how their homegrown AI algorithm was able to analyze abdominal CT scans and link body composition measurements to the presence of disease.
Opportunistic screening is a sort of holy grail for radiology, with the potential to help radiologists find pathology from scans ordered for other clinical indications.
- Some researchers specifically are focusing on analysis of body composition characteristics derived from CT scans like muscle, fat, and bone that could be biomarkers for hidden pathology – and AI is key because it can process mountains of patient data without getting tired.
In the new paper, researchers from the NIH and the University of Wisconsin tested the concept of AI-based body composition analysis on a massive database of 118k patients who got abdominal CT scans from 2000 to 2021.
- They analyzed the scans with their own internally developed AI tool that measures 13 features of body composition, from volume and attenuation in different organs to area of subcutaneous adipose tissue.
Their goal was to correlate the AI measurements with actual presence of disease, as well as other factors that could affect body composition like age and sex. They found …
- AI-based body composition metrics varied by age and sex, confirming previous studies.
- AI metrics also correlated with the four systemic diseases studied, specifically cancer, cardiovascular disease, diabetes mellitus, and cirrhosis.
- The predictive power of different metrics varied by disease, from a high of 13 measures for diabetes to a low of nine for cancer.
What’s the real-world impact of the study?
- In addition to validating the concept of AI-based opportunistic screening on a broad scale, the findings could be used to establish a set of normal values for body composition that also take into account the impact of systemic disease on these measurements.
The Takeaway
The new study is a bit technical, but it’s an important milestone on the path to opportunistic screening. It not only demonstrates the concept’s feasibility, but also begins to establish the normal values needed to actually implement screening programs in the real world.
|
|
|
Future-Proof Your Medical Imaging
Switch to Optum’s fully managed, cloud-native enterprise imaging platform. Secure, scalable, seamless. Learn more today on how to future-proof your medical imaging!
|
|
Give Patients a Clear Path to Accessing Medical Data
Clearpath is a simple integration that empowers digital delivery of medical records and images. Request a demo today to find out how you can ditch the disc and give your patients and third parties instant access to digital data.
|
|
Catch What You’ve Missed on Unboxing AI
Missed an episode of Unboxing AI, CARPL’s video series on AI in radiology? Check out all the past episodes on their YouTube channel.
|
|
- FDA Guidelines on Off-Label Communications: The FDA has started off 2025 in a regulatory frenzy. Last week the agency issued new guidelines for medical firms on how they can communicate unapproved (off-label) uses for approved products to healthcare providers. The guidance focuses on how companies can convey scientific information on unapproved uses to providers without running afoul of FDA rules prohibiting vendors from marketing products for unapproved uses. The rules finalize a draft guidance issued in October 2023, and update guidelines on off-label communications from 2014.
- Dr. AI Will See You Now: Speaking of AI regulation, a bill introduced into the U.S. Congress would make it possible to classify AI and machine learning technologies as healthcare practitioners who are eligible to prescribe drugs. H.R. 238 was introduced by Rep. David Schweikert (R-AZ) and would amend federal law to allow AI-based prescribing if “authorized by the State involved” and approved or cleared by the FDA. The bill opens a new wrinkle in the debate over government regulation of AI for medical use.
- When Breakthrough Devices Don’t Break Through: Medical device and software developers often tout their receipt of “breakthrough device” designation from the FDA. But getting breakthrough status doesn’t necessarily mean the products will reach the market. Legal analyst Bradley Merrill Thompson breaks down the breakthrough program, noting that in a recent update FDA said that only 12% of breakthrough-designated devices were ultimately cleared or approved. Thompson speculates that the FDA actually reviews breakthrough devices more closely than other products, which could stifle companies with “overly burdensome requests for data.”
- Too Much Contrast for Women? Are women getting too much iodine contrast media during imaging exams? That’s the implication of a new study in European Radiology that suggests setting contrast dose using characteristics like body weight or type of imaging study results in women getting too much contrast. Researchers found that in a population of 274 men and women who got identical contrast doses (120 and 110 mL), women had 16% higher attenuation values at 120 mL and 23% more at 100 mL. They suggested basing contrast dose on blood volume instead.
- AI Classifies Coronary Stenosis: In another new paper in European Radiology, an AI algorithm from French developer Spimed-AI successfully classified severe stenosis on coronary CT angiography exams. Researchers used CorEx 2.0 to assess CCTA scans in 50 patients, finding the algorithm had 100% agreement with radiologists in identifying patients with 70% stenosis in their coronary arteries. Using automated AI tools like CorEx for stenosis assessment could speed up reporting and reduce inter-reader variability.
- United Imaging to Triple Texas HQ: United Imaging plans a major expansion of its North American headquarters and manufacturing space near Houston, Texas, tripling the size of its manufacturing square footage. The company opened its current production facility just over four years ago, but its headcount has grown at a 60% annual rate since then and it now has local production for all four of its imaging modalities. The company has also been growing its presence in South America and Canada from the Houston HQ.
- OXOS Lands X-Ray Clearance: Portable X-ray developer OXOS Medical received FDA clearance for MC2, a new cordless portable X-ray system. MC2 features a nine-inch digital detector and supports both fluoroscopy and dynamic digital radiography. OXOS is touting the system’s lightweight design, small radiation scatter area, and low radiation output, which reduces the space and size needed to operate the system relative to larger X-ray rooms. OXOS raised $23M in 2023 to commercialize its technology and launched its Micro C portable X-ray system in 2021.
- Portable MRI for Stroke: Meanwhile, New Zealand device developer Wellumio is laying the groundwork for a U.S. launch of its Axana portable MRI scanner for stroke detection. Axana is a cart-based head-only scanner that can be rolled to the patient bedside for quick assessment in emergency departments and other locations. Axana is based on pulsed-gradient free mapping technology, which Wellumio believes enables it to visualize MR properties of brain tissue without bulky components. The company has set up a California office, hired executives, and is planning clinical trials.
- Bayer MRI Contrast Agent Makes Progress: A new high-relaxivity MRI contrast agent from Bayer that could sharply reduce gadolinium contrast dose made progress in clinical studies. The company’s gadoquatrane macrocyclic agent successfully met primary and main secondary endpoints in the pivotal phase III QUANTI studies, which are investigating a dose of 0.04 mmol Gd/kg body weight, a 60% reduction compared to a standard dose at 0.1 mmol Gd/kg body weight. If approved, gadoquatrane would compete with high-relaxivity gadolinium agents recently launched by Guerbet and Bracco.
- Izotropic Advances Breast CT Scanner: Breast CT developer Izotropic moved its IzoView scanner closer to market by filing an FDA notice to get the agency’s feedback on the design of a clinical study to support a regulatory application. Izotropic is positioning the system as an adjunct to DBT screening, especially in women with dense breast tissue. IzoView is based on research on contrast-enhanced breast CT conducted at UC Davis; one advantage of the technology is spatial resolution that’s 100X higher than breast MRI.
- SimBioSys Taps Stevens as CEO: AI developer SimBioSys has named veteran imaging executive Stacey Stevens as president and CEO. Stevens previously ran a women’s health consulting firm, and before that was at iCAD for 16 years, where she served in a variety of roles including president and CEO. SimBioSys is developing AI-based solutions for analyzing cancer, including its TumorSight Viz application for 3D spatial visualization of breast cancer using MRI scans.
- Imaging Volume to Outstrip Workforce: A new report from Signify Research predicts that global growth in imaging volume will outstrip workforce growth over the next five years. The company’s Healthcare Workforce Database – 2024 report forecasts that volumes will grow 5.1% annually from 2024-2028, but the workforce of medical practitioners, nurses, and allied health professionals will only grow 3.3% a year. The discrepancy will increase with the aging population and expansion of screening programs.
- Healthcare Spending Accelerated in 2023: U.S. healthcare spending accelerated in 2023 compared to 2022. The latest figures from CMS show that spending grew 7.5% in 2023 to reach $4.9T or $14.6k per person, with spending hitting 17.6% of gross domestic product. This compares to spending growth of 4.6% in 2022. The silver lining is that the accelerated growth was due to more people covered by Medicare and private insurance, with the percentage of covered U.S. population hitting 93%.
|
|
3 Good Reasons to Add Mammography
There are three good reasons to add mammography services at your imaging site as providers expect higher demand for breast imaging services. Get the facts about mammography on this resource page from Siemens Healthineers.
|
|
Heart Failure Screening at Home and in Primary Care
Heart failure is the number one cause of hospitalization in people over 65. The SYMPHONY study is investigating a screening strategy of point-of-care AI echo and NT-proBNP in primary practice and general community settings. Learn more on this page from Us2.ai.
|
|
How AI and Informatics Are Changing Radiology
How are AI-powered health informatics solutions reshaping radiology? Watch this on-demand webinar from DeepHealth to see how informatics is improving the speed and accuracy of cancer detection while giving clinicians advanced operational insights.
|
|
- Tools for Lung Cancer Screening in Europe: As lung cancer screening programs gear up to launch across various European countries, the integration of AI nodule detection tools promises to enhance the accuracy of low-dose CT scans. Watch this video from Riverain Technologies to learn more.
- Get the 2024 Radiology Practice Development Report: Medality surveyed more than 3,300 radiologists and discovered the most critical training gaps and growth opportunities in radiology for its 2024 Radiology Practice Development Report. Download your complimentary report today.
- AI for Lung Cancer Diagnosis and Screening: Check out this comprehensive new eBook from Calantic by Bayer on the role of AI in lung cancer diagnosis and screening. It explores AI’s potential role in improving lung cancer screening strategies, identifying high-risk individuals, and enhancing diagnostic accuracy. Download it today.
- Feel the Freedom of Helium-Free MRI: Lift limitations and experience MRI excellence with Philips BlueSeal, the industry’s lightest, vent pipe-free, high-performance, helium-free 1.5T scanner. Save on helium and energy costs, achieve precise AI-enhanced diagnoses, enjoy faster scans, and optimized workflows. Learn more today.
- PACS that Scales to Fit Your Needs: IntelePACS from Intelerad streamlines your reading workflow from start to finish. With faster load times, centralized access, and integration with your EHR, it provides a smooth and efficient workflow your radiologists will prefer. Discover how IntelePACS can transform your radiology practice.
- AI for Pediatric Fracture Detection: Pediatric fractures are common but can be easily missed on radiography. Meanwhile, AI tools for fracture detection have mostly been tested in adults. Learn how Gleamer’s BoneView AI solution helped clinicians find fractures in kids in a recent research study.
- Start at the Source to Improve MRI: Looking for ways to improve MRI speed and image quality while addressing broader concerns in healthcare? The answer may lie in proven MRI physics in your existing scanner – learn how to unlock it with STAGE from SpinTech MRI.
- Your In-Workflow Copilot Experience: PowerScribe Smart Impression from Microsoft harnesses generative AI to automatically generate draft impressions and recommendations, saving you time and reducing workload-related stress. Learn how it can become your in-workflow copilot today.
- Unprecedented Insights Made Possible with AI: With the largest normative dataset of whole-body imaging in the world, Prenuvo’s AI researchers partner with the best academic minds to understand – like never before – what “normal” aging means. Learn about their work today.
- Takeaways from RSNA 2024: In this article, Merge by Merative offers a look at some of the major themes from the meeting, including a clinician’s view of cybersecurity, enterprise imaging strategies, and more.
- AI-Empowered CT Workflow: CT systems from United Imaging are designed for high image quality and low dose, and their AI-empowered workflow enables fast and reproducible positioning, helping you image patients with confidence. Learn more on this page.
- Transform Healthcare with the Cloud: Discover how Optum’s cloud-based medical imaging solutions can slash costs and streamline radiology operations. Visit their website today to unlock a wealth of healthcare insights and resources tailored just for professionals like you.
- Key Takeaways from RSNA: PocketHealth CEO Rishi Nayyar highlights three major themes from RSNA: engaging patients and providers to close care gaps, leveraging AI to improve patient care, and creating efficiencies to address financial challenges. Read more here.
- Leading the Way in AI Transparency: There’s a need to better inform radiologists about AI’s role when interpreting images and generating measurements. Visage Imaging’s Visage 7 can display text in the viewer indicating that AI was used as a diagnostic aid – find out how it works today.
- Making Quantum Technology More Accessible: The expansion of Siemens Healthineers photon-counting CT portfolio with the NAEOTOM Alpha class makes the results possible from Quantum Technology accessible to more clinicians and patients.
- The Growth of AI in Pulmonology: Learn more about the capabilities of AI for chest imaging in this on-demand webinar from Blackford. You’ll hear pulmonology professionals discuss several promising areas, from acute imaging through chest X-ray analysis to lung cancer screening.
- Unify Your Imaging to Improve Clinical Outcomes: Mach7 empowers clinicians with tools to promote better patient care. Find out how their eUnity zero-footprint universal viewer brings together the patient imaging record to provide you with all the information you need to know – when you need it.
- Medical Imaging Data for Improved Research: The need for high-quality medical imaging data is crucial to drive advancements in diagnostics and treatment. Schedule a demo today to learn how Enlitic’s ENDEX for data standardization and ENCOG for data anonymization enable researchers to access superior data while optimizing resources.
- Enterprise Imaging for Cardiology: Discover how AGFA HealthCare’s Enterprise Imaging for Cardiology solution can revolutionize cardiologists’ workflow in this on-demand webcast. You’ll learn how it can foster collaboration, streamline operations, and optimize your practice.
|
|
|
|
|
